Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing elective surgery and gastrointestinal endoscopies, according to new ...

Finerenone further reduces albuminuria in patients already on triple therapy for CKD with type 2 diabetes (SGLT2i, GLP-1 RA, and ACEi or ARB), which might lead to better kidney outcomes in this ...

Results from the trial included a 140% average increase in GLP-1 levels in the body leading to an average weight loss of 9 pounds in 8 weeks and up to 25 pounds in 12 weeks in participants.

LifeVantage (LFVN) announced results from a human clinical trial performed on the new MindBody GLP-1 System. Results from the trial included a 140% average increase in GLP-1 levels in the body ...

What Are GLP-1 Medications and How Do They Work? GLP-1 (glucagon-like peptide-1) medications work by mimicking a hormone that regulates blood sugar and appetite. They slow down digestion ...

Dallas-based Smoothie King will blend up five drinks, dubbed “Ozempic Smoothies” that target people taking GLP-1 medications, the company said in an email to The Dallas Morning News.

From 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium glucose cotransporter 2 (SGLT2) inhibitors among individuals with type 1 ...

DALLAS, Oct. 29, 2024 /PRNewswire/ -- Smoothie King, the world's leading smoothie brand, is proud to announce the launch of its GLP-1 Support Menu for guests using GLP-1 agonists to help them achieve ...

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications" Sabrina Weiss is the Editorial Assistant of PEOPLE's food ...

New Resource Offers Tailored Smoothie Menu for Individuals Incorporating GLP-1 Weight Loss Medications into Their Health & Wellness Routines DALLAS, Oct. 29, 2024 /PRNewswire/ -- Smoothie King ...

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications" Smoothie King; George Frey/Bloomberg via Getty Smoothie King has a ...

PHILADELPHIA — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with a significant decrease in the risk for early-onset colorectal cancer (EO-CRC) in patients with ...